Inflammation,
Journal Year:
2021,
Volume and Issue:
44(5), P. 1815 - 1830
Published: April 21, 2021
Abstract
Mesenchymal
stem
cells
(MSCs)
and
their
derived
extracellular
vesicles
have
been
reported
as
promising
tools
for
the
management
of
heart
disease.
The
aim
this
study
was
to
explore
function
adipose-derived
MSCs
(adMSCs)-derived
exosomes
(Exo)
in
progression
myocardial
infarction
(MI)
molecules
involved.
Mouse
cardiomyocytes
were
treated
with
oxygen-glucose
deprivation
(OGD)
mimic
an
MI
condition
vitro
.
adMSCs-derived
Exo
identified
administrated
into
OGD-treated
cardiomyocytes,
then
viability
apoptosis
cells,
secretion
fibrosis-
inflammation-related
cytokines
determined.
Differentially
expressed
microRNAs
(miRNAs)
after
treatment
screened
using
a
microarray
analysis.
downstream
regulated
by
miR-671
explored
through
bioinformatic
Involvements
transforming
growth
factor
beta
receptor
2
(TGFBR2)
exosome-mediated
events
confirmed
rescue
experiments.
A
murine
model
induced
functional
experiments
vivo
Compared
phosphate-buffered
saline
treatment,
significantly
enhanced
while
reduced
fibrosis
inflammation
both
upregulated
treatment.
Downregulation
blocked
protective
functions
Exo.
targeted
TGFBR2
suppressed
phosphorylation
Smad2.
Artificial
downregulation
cardiomyocytes.
This
suggested
that
adMSC-derived
exosomal
directly
targets
reduces
Smad2
alleviate
MI-like
symptoms
Regenerative Therapy,
Journal Year:
2020,
Volume and Issue:
14, P. 136 - 153
Published: Feb. 21, 2020
There
is
enormous
global
anticipation
for
stem
cell-based
therapies
that
are
safe
and
effective.
Numerous
pre-clinical
studies
present
encouraging
results
on
the
therapeutic
potential
of
different
cell
types
including
tissue
derived
cells.
Emerging
evidences
in
fields
research
suggest
several
safe,
whereas
their
application
effectiveness
remain
challenged.
Multiple
factors
influence
treatment
outcomes
proposed
immunocompatibility
potency,
owing
to
variations
origin,
ex-vivo
methodologies
preparation
handling
This
communication
gives
an
overview
literature
data
cells
potentially
promising
regenerative
therapy.
As
a
case
point,
recent
trends
development
mesenchymal
(MSCs)
therapy
considered
detail.
MSCs
can
be
isolated
from
variety
tissues
organs
human
body
bone
marrow,
adipose,
synovium,
perinatal
tissues.
However,
MSC
products
sources
exhibit
unique
or
varied
levels
abilities.
The
review
finally
focuses
adipose
tissue-derived
(ASCs),
with
properties
such
as
easier
accessibility
abundance,
excellent
proliferation
differentiation
capacities,
low
immunogenicity,
immunomodulatory
many
other
trophic
properties.
suitability
ASCs,
strategies
improve
innate
capacities
general
highlighted
among
others.
Stem Cell Research & Therapy,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 26, 2023
Abstract
Wound
healing
is
a
dynamic
and
highly
sequential
process
involving
series
of
overlapping
spatial
temporal
phases,
including
hemostasis,
inflammation,
proliferation,
tissue
remodeling.
Mesenchymal
stem
cells
(MSCs)
are
multipotent
with
self-renewal,
multidirectional
differentiation
potential,
paracrine
regulation.
Exosomes
subcellular
vesicular
components
30–150
nm
in
size
novel
carriers
intercellular
communication
regulating
the
biological
behaviors
skin
cells.
Compared
to
MSCs,
MSC-derived
exosomes
(MSC-exos)
possess
lower
immunogenicity,
easy
storage,
effective
activity.
MSC-exos,
mainly
derived
from
adipose-derived
(ADSCs),
bone
marrow-derived
MSCs
(BMSCs),
human
umbilical
cord
(hUC-MSCs),
other
cell
types,
play
role
shaping
activity
fibroblasts,
keratinocytes,
immune
cells,
endothelial
diabetic
wounds,
inflammatory
wound
repair,
even
wound-related
keloid
formation.
Therefore,
this
study
focuses
on
specific
roles
mechanisms
different
MSC-exos
healing,
as
well
current
limitations
various
perspectives.
Deciphering
properties
crucial
providing
promising
cell-free
therapeutic
tool
for
cutaneous
regeneration.
Graphical
Stem Cell Research & Therapy,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: April 29, 2021
Abstract
Background
Diabetic
wounds
threaten
the
health
and
quality
of
life
patients
their
treatment
remains
challenging.
ADSC-derived
exosomes
have
shown
encouraging
results
in
enhancing
diabetic
wound
healing.
However,
how
to
use
effectively
is
a
problem
that
needs
be
addressed
at
present.
Methods
A
mouse
skin
model
was
established.
(ADSC-Exos)
were
isolated,
vitro
application
evaluated
using
human
umbilical
vein
endothelial
cells
(HUVECs)
dermal
fibroblasts
(HDFs).
After
preparation
characterization
scaffold
acellular
amniotic
membrane
(hAAM)
loaded
with
ADSC-Exos
vitro,
they
transplanted
into
vivo
healing
phenomena
observed
by
histological
immunohistochemical
analyses
identify
mechanism
exosome-hAAM
composites.
Results
The
hAAM
dressing
very
suitable
for
delivery
exosomes.
enhanced
proliferation
migration
HDFs
promoted
tube
formation
HUVECs
vitro.
In
from
showed
hAAM-Exos
accelerated
regulating
inflammation,
stimulating
vascularization,
promoting
production
extracellular
matrix.
Conclusion
Exosome-incorporated
scaffolds
great
potential
healing,
while
also
providing
strong
evidence
future
clinical
applications
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(20)
Published: May 10, 2023
Abstract
Over
the
last
decade,
adipose‐derived
stem
cells
(ADSCs)
have
attracted
increasing
attention
in
field
of
regenerative
medicine.
ADSCs
appear
to
be
most
advantageous
cell
type
for
therapies
owing
their
easy
accessibility,
multipotency,
and
active
paracrine
activity.
This
review
highlights
current
challenges
translating
ADSC‐based
into
clinical
settings
discusses
novel
strategies
overcome
limitations
ADSCs.
To
further
establish
as
an
emerging
platform
medicine,
this
also
provides
update
on
advancements
field,
including
fat
grafting,
wound
healing,
bone
regeneration,
skeletal
muscle
repair,
tendon
reconstruction,
cartilage
cardiac
nerve
regeneration.
are
expected
more
tissue‐specific
increasingly
important
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(40)
Published: June 21, 2023
Abstract
Engineered
skin
substitutes
derived
from
human
significantly
reduce
inflammatory
reactions
mediated
by
foreign/artificial
materials
and
are
consequently
easier
to
use
for
clinical
application.
Type
I
collagen
is
a
main
component
of
the
extracellular
matrix
during
wound
healing
has
excellent
biocompatibility,
platelet‐rich
plasma
can
be
used
as
initiator
cascade.
Adipose
mesenchymal
stem
cell
exosomes
crucial
tissue
repair
play
key
roles
in
enhancing
regeneration,
promoting
angiogenesis,
regulating
inflammation,
remodeling
matrix.
Herein,
plasma,
which
provide
natural
supports
keratinocyte
fibroblast
adhesion,
migration,
proliferation,
mixed
form
stable
3D
scaffold.
added
scaffold
improve
performance
engineered
skin.
The
physicochemical
properties
this
cellular
analyzed,
effect
evaluated
full‐thickness
defect
mouse
model.
reduces
level
inflammation
promotes
proliferation
angiogenesis
accelerate
healing.
Proteomic
analysis
shows
that
exhibit
anti‐inflammatory
proangiogenic
effects
collagen/platelet‐rich
scaffolds.
proposed
method
provides
new
therapeutic
strategy
theoretical
basis
regeneration
repair.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(4)
Published: June 17, 2023
Abstract
Regeneration
is
a
complex
process
affected
by
many
elements
independent
or
combined,
including
inflammation,
proliferation,
and
tissue
remodeling.
Stem
cells
class
of
primitive
with
the
potentiality
differentiation,
regenerate
self‐replication,
multidirectional
immunomodulatory
functions.
their
cytokines
not
only
inextricably
linked
to
regeneration
ectodermal
skin
tissues,
but
also
can
be
used
for
treatment
variety
chronic
wounds.
produce
exosomes
in
paracrine
manner.
cell
play
an
important
role
regeneration,
repair,
accelerated
wound
healing,
biological
properties
which
are
similar
stem
cells,
while
safer
more
effective.
Skin
bone
tissues
critical
organs
body,
essential
sustaining
life
activities.
The
weak
repairing
ability
leads
pronounced
impact
on
quality
patients,
could
alleviated
treatment.
However,
there
obstacles
that
trough
improved
bioavailability.
This
paper
summarizes
applications
mechanisms
healing.
We
propose
new
ways
utilizing
through
different
nanoformulations,
liposomes
nanoliposomes,
polymer
micelles,
microspheres,
hydrogels,
scaffold
microneedles,
improve
use
healing
regeneration.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 2344 - 2344
Published: Jan. 25, 2023
The
native
role
of
extracellular
vesicles
(EVs)
in
mediating
the
transfer
biomolecules
between
cells
has
raised
possibility
to
use
them
as
therapeutic
vehicles.
development
therapies
based
on
EVs
is
now
expanding
rapidly;
here
we
will
describe
current
knowledge
different
key
points
regarding
a
clinical
setting.
These
are
related
cell
sources
EVs,
isolation,
storage,
and
delivery
methods,
well
modifications
releasing
for
improved
production
EVs.
Finally,
depict
application
trials,
considering
impact
COVID-19
pandemic
these
therapies,
pointing
out
that
although
it
promising
therapy
human
diseases,
still
initial
phase
its
patients.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1036 - 1036
Published: Jan. 5, 2023
Viruses
share
many
attributes
in
common
with
extracellular
vesicles
(EVs).
The
cellular
machinery
that
is
used
for
EV
production,
packaging
of
substrates
and
secretion
also
commonly
manipulated
by
viruses
replication,
assembly
egress.
can
increase
production
or
manipulate
EVs
to
spread
their
own
genetic
material
proteins,
while
play
a
key
role
regulating
viral
infections
transporting
immunomodulatory
molecules
antigens
initiate
antiviral
immune
responses.
Ultimately,
the
interactions
between
are
highly
interconnected,
which
has
led
interesting
discoveries
associated
roles
progression
different
diseases,
as
well
new
promise
combinational
therapeutics.
In
this
review,
we
summarize
relationships
discuss
major
developments
from
past
five
years
engineering
virus-EV
therapies.